GLENMARK LIFE SCIENCES LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 853.4 INR | -0.55% |
|
-1.65% | +29.88% |
| 05-15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
| 04-25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLENMARK LIFE SCIENCES LIMITED | Other Pharmaceuticals | -0.55% | -1.65% | +29.88% | +41.82% | - | 1.25B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- GLS Stock
- Charts Glenmark Life Sciences Limited
- Comparison Chart
